Ribosomal Protein, Mitochondrial ribosomal S18
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000314 | organellar small ribosomal subunit | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005763 | mitochondrial small ribosomal subunit | 3 | 1 |
GO:0015935 | small ribosomal subunit | 4 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0044391 | ribosomal subunit | 3 | 1 |
GO:0098798 | mitochondrial protein-containing complex | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:1990904 | ribonucleoprotein complex | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0043631 | RNA polyadenylation | 6 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 175 | 181 | PF00089 | 0.394 |
CLV_NRD_NRD_1 | 237 | 239 | PF00675 | 0.603 |
CLV_NRD_NRD_1 | 55 | 57 | PF00675 | 0.472 |
CLV_PCSK_KEX2_1 | 237 | 239 | PF00082 | 0.603 |
CLV_PCSK_KEX2_1 | 311 | 313 | PF00082 | 0.461 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.481 |
CLV_PCSK_PC1ET2_1 | 311 | 313 | PF00082 | 0.461 |
CLV_PCSK_PC1ET2_1 | 57 | 59 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 139 | 143 | PF00082 | 0.380 |
CLV_PCSK_SKI1_1 | 164 | 168 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 237 | 241 | PF00082 | 0.639 |
CLV_PCSK_SKI1_1 | 281 | 285 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 295 | 299 | PF00082 | 0.483 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.706 |
DOC_MAPK_gen_1 | 164 | 173 | PF00069 | 0.378 |
DOC_MAPK_MEF2A_6 | 120 | 127 | PF00069 | 0.460 |
DOC_MAPK_MEF2A_6 | 167 | 175 | PF00069 | 0.382 |
DOC_PP4_FxxP_1 | 118 | 121 | PF00568 | 0.502 |
DOC_PP4_FxxP_1 | 179 | 182 | PF00568 | 0.376 |
DOC_PP4_FxxP_1 | 315 | 318 | PF00568 | 0.448 |
DOC_USP7_MATH_1 | 239 | 243 | PF00917 | 0.585 |
DOC_USP7_UBL2_3 | 128 | 132 | PF12436 | 0.396 |
DOC_USP7_UBL2_3 | 295 | 299 | PF12436 | 0.483 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.508 |
LIG_14-3-3_CanoR_1 | 238 | 248 | PF00244 | 0.678 |
LIG_BIR_III_2 | 39 | 43 | PF00653 | 0.572 |
LIG_BRCT_BRCA1_1 | 186 | 190 | PF00533 | 0.401 |
LIG_deltaCOP1_diTrp_1 | 61 | 65 | PF00928 | 0.400 |
LIG_EH_1 | 180 | 184 | PF12763 | 0.364 |
LIG_FHA_1 | 218 | 224 | PF00498 | 0.407 |
LIG_FHA_1 | 317 | 323 | PF00498 | 0.467 |
LIG_FHA_2 | 34 | 40 | PF00498 | 0.464 |
LIG_FHA_2 | 44 | 50 | PF00498 | 0.484 |
LIG_FHA_2 | 91 | 97 | PF00498 | 0.407 |
LIG_LIR_Gen_1 | 124 | 134 | PF02991 | 0.398 |
LIG_LIR_Gen_1 | 30 | 35 | PF02991 | 0.450 |
LIG_LIR_Gen_1 | 79 | 90 | PF02991 | 0.483 |
LIG_LIR_Nem_3 | 124 | 129 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 30 | 34 | PF02991 | 0.437 |
LIG_LIR_Nem_3 | 79 | 85 | PF02991 | 0.483 |
LIG_LYPXL_S_1 | 175 | 179 | PF13949 | 0.384 |
LIG_Pex14_2 | 179 | 183 | PF04695 | 0.375 |
LIG_Pex14_2 | 213 | 217 | PF04695 | 0.411 |
LIG_SH2_CRK | 126 | 130 | PF00017 | 0.400 |
LIG_SH2_CRK | 131 | 135 | PF00017 | 0.390 |
LIG_SH2_PTP2 | 31 | 34 | PF00017 | 0.414 |
LIG_SH2_STAP1 | 14 | 18 | PF00017 | 0.451 |
LIG_SH2_STAT5 | 226 | 229 | PF00017 | 0.421 |
LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.418 |
LIG_SH3_3 | 151 | 157 | PF00018 | 0.400 |
LIG_SH3_3 | 283 | 289 | PF00018 | 0.475 |
LIG_SUMO_SIM_anti_2 | 30 | 36 | PF11976 | 0.507 |
LIG_TRAF2_1 | 194 | 197 | PF00917 | 0.483 |
LIG_TRAF2_1 | 46 | 49 | PF00917 | 0.587 |
MOD_CDK_SPxxK_3 | 43 | 50 | PF00069 | 0.591 |
MOD_CK1_1 | 306 | 312 | PF00069 | 0.469 |
MOD_CK1_1 | 316 | 322 | PF00069 | 0.495 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.524 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.588 |
MOD_Cter_Amidation | 54 | 57 | PF01082 | 0.467 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.586 |
MOD_GSK3_1 | 135 | 142 | PF00069 | 0.363 |
MOD_GSK3_1 | 199 | 206 | PF00069 | 0.438 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.559 |
MOD_GSK3_1 | 303 | 310 | PF00069 | 0.468 |
MOD_N-GLC_1 | 262 | 267 | PF02516 | 0.523 |
MOD_N-GLC_1 | 83 | 88 | PF02516 | 0.427 |
MOD_NEK2_1 | 13 | 18 | PF00069 | 0.521 |
MOD_NEK2_1 | 141 | 146 | PF00069 | 0.392 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.593 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.468 |
MOD_NEK2_1 | 304 | 309 | PF00069 | 0.462 |
MOD_NEK2_1 | 313 | 318 | PF00069 | 0.454 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.537 |
MOD_PIKK_1 | 16 | 22 | PF00454 | 0.527 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.397 |
MOD_PIKK_1 | 253 | 259 | PF00454 | 0.581 |
MOD_PKA_1 | 237 | 243 | PF00069 | 0.628 |
MOD_PKA_2 | 237 | 243 | PF00069 | 0.616 |
MOD_Plk_1 | 262 | 268 | PF00069 | 0.494 |
MOD_Plk_1 | 279 | 285 | PF00069 | 0.603 |
MOD_Plk_1 | 83 | 89 | PF00069 | 0.422 |
MOD_Plk_2-3 | 262 | 268 | PF00069 | 0.587 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.507 |
MOD_SUMO_rev_2 | 109 | 115 | PF00179 | 0.441 |
TRG_AP2beta_CARGO_1 | 79 | 89 | PF09066 | 0.481 |
TRG_DiLeu_BaEn_1 | 30 | 35 | PF01217 | 0.437 |
TRG_ENDOCYTIC_2 | 126 | 129 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 176 | 179 | PF00928 | 0.383 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.446 |
TRG_ENDOCYTIC_2 | 31 | 34 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.404 |
TRG_ER_diArg_1 | 53 | 56 | PF00400 | 0.449 |
TRG_NES_CRM1_1 | 257 | 267 | PF08389 | 0.581 |
TRG_NLS_MonoExtC_3 | 55 | 60 | PF00514 | 0.484 |
TRG_NLS_MonoExtN_4 | 295 | 302 | PF00514 | 0.482 |
TRG_NLS_MonoExtN_4 | 54 | 60 | PF00514 | 0.484 |
TRG_Pf-PMV_PEXEL_1 | 228 | 232 | PF00026 | 0.503 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PD70 | Leptomonas seymouri | 90% | 100% |
A0A0S4JTC8 | Bodo saltans | 67% | 100% |
A0A3S5H825 | Leishmania donovani | 100% | 100% |
A0A422NIU3 | Trypanosoma rangeli | 84% | 100% |
A4HP99 | Leishmania braziliensis | 94% | 100% |
D0A3A4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 83% | 100% |
E9AT08 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
Q4Q1J0 | Leishmania major | 98% | 100% |
V5BKY9 | Trypanosoma cruzi | 82% | 100% |